Michael’s Domain
The fact that everything looks different doesn’t mean that all has changed…
Michael Jeltsch
1 min read • 80 wordsFinnish/German biochemist researching and teaching at the University of Helsinki
Michael Jeltsch
- Moved from Germany to Finland in 1995
- PhD (University of Helsinki 2003 with Kari Alitalo )
- Discovery and characterization of the first lymphangiogenic growth factors VEGF-C and VEGF-D ( Jeltsch et al. 1997, Science ; Achen et al. 1998, PNAS )
- Experience in three biotech startups with numerous patents for biopharmaceuticals
- Biopharmaceuticals progressed into clinical trials: VGX-100 (up to phase 1), Lymfactin (up to phase 2), and OPT-302 (up to phase 3), CYV-101 currently in preparation.